Literature DB >> 19682053

Landau-Kleffner syndrome and CSWS syndrome: treatment with intravenous immunoglobulins.

Willem F M Arts1, Femke K Aarsen, Marjan Scheltens-de Boer, Coriene E Catsman-Berrevoets.   

Abstract

This study reports results of therapy with immunoglobulin in children with Landau-Kleffner syndrome (LKS) or the syndrome of continuous spikes and waves during sleep (CSWS syndrome). In a prospective study, children diagnosed between 2002 and 2006 with either LKS or CSWS syndrome were treated soon after diagnosis with intravenous courses of immunoglobulin (IVIg). We compared the results with those reported in the literature and with data from a retrospective survey of our earlier patients. Six children (two girls), aged 4-9 years, were included. Three had LKS, and three had CSWS syndrome. One child-with typical LKS-had been treated with prednisone before (without response). No patient had seizures during IVIg treatment and follow-up. Their electroencephalography (EEG) findings did not improve. Neuropsychological improvement occurred in one child with CSWS syndrome. Three children did not show any beneficial effect; they were subsequently treated with steroids, one with a clearly positive result. We conclude that successful treatment of LKS and CSWS syndrome with IVIg occurs occasionally. However, the improvement cannot always be clearly attributed to this. It might also reflect the natural course of the disease. Although the temporal relation between IVIg treatment and clinical improvement cannot be denied in individual patients, its real value remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682053     DOI: 10.1111/j.1528-1167.2009.02221.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

Review 1.  "Electro-clinical syndromes" with onset in paediatric age: the highlights of the clinical-EEG, genetic and therapeutic advances.

Authors:  Pasquale Parisi; Alberto Verrotti; Maria Chiara Paolino; Rosa Castaldo; Filomena Ianniello; Alessandro Ferretti; Francesco Chiarelli; Maria Pia Villa
Journal:  Ital J Pediatr       Date:  2011-12-19       Impact factor: 2.638

Review 2.  Immune therapy in autism: historical experience and future directions with immunomodulatory therapy.

Authors:  Michael G Chez; Natalie Guido-Estrada
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

3.  "Epileptic encephalopathy" of infancy and childhood: electro-clinical pictures and recent understandings.

Authors:  Pasquale Parisi; Alberto Spalice; Francesco Nicita; Laura Papetti; Fabiana Ursitti; Alberto Verrotti; Paola Iannetti; Maria Pia Villa
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

4.  Epileptic encephalopathies in adults and childhood.

Authors:  Zekiye Kural; Ali Fahir Ozer
Journal:  Epilepsy Res Treat       Date:  2012-09-27

5.  Diagnosis and management of epileptic encephalopathies in children.

Authors:  Puneet Jain; Suvasini Sharma; Manjari Tripathi
Journal:  Epilepsy Res Treat       Date:  2013-07-22

6.  Continuous Spikes and Waves during Sleep: Electroclinical Presentation and Suggestions for Management.

Authors:  Iván Sánchez Fernández; Kevin E Chapman; Jurriaan M Peters; Chellamani Harini; Alexander Rotenberg; Tobias Loddenkemper
Journal:  Epilepsy Res Treat       Date:  2013-08-06

7.  Epileptic encephalopathies: an overview.

Authors:  Sonia Khan; Raidah Al Baradie
Journal:  Epilepsy Res Treat       Date:  2012-11-20

8.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

9.  Intravenous immunoglobulins for epilepsy.

Authors:  JinSong Geng; JianCheng Dong; Youping Li; HengJian Ni; Kui Jiang; Li Li Shi; GuoHua Wang
Journal:  Cochrane Database Syst Rev       Date:  2019-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.